-
1
-
-
0021958939
-
Inflammatory breast cancer: The experience of the Surveillance, Epidemiology, and End Results (SEER) Program
-
Levine PH, Steinhorn SC, Ries LG, et al. Inflammatory breast cancer: the experience of the Surveillance, Epidemiology, and End Results (SEER) Program. J Natl Cancer Inst (Bethesda) 1985; 74:291-297.
-
(1985)
J Natl Cancer Inst (Bethesda)
, vol.74
, pp. 291-297
-
-
Levine, P.H.1
Steinhorn, S.C.2
Ries, L.G.3
-
3
-
-
0024445237
-
Inflammatory symptoms in breast cancer. Correlations with growth rate, clinicopathologic variables, and evolution
-
Tabbane F, Bahi J, Rahal K, et al. Inflammatory symptoms in breast cancer. Correlations with growth rate, clinicopathologic variables, and evolution. Cancer (Phila) 1989; 64:2081-2089.
-
(1989)
Cancer (Phila)
, vol.64
, pp. 2081-2089
-
-
Tabbane, F.1
Bahi, J.2
Rahal, K.3
-
4
-
-
0029083919
-
Inflammatory carcinomas of the breast: A clinical, pathological, or a clinical and pathological definition?
-
Bonnier P, Charpin C, Lejeune C. Inflammatory carcinomas of the breast: a clinical, pathological, or a clinical and pathological definition? Int J Cancer 1995; 62:382-385.
-
(1995)
Int J Cancer
, vol.62
, pp. 382-385
-
-
Bonnier, P.1
Charpin, C.2
Lejeune, C.3
-
6
-
-
0022860622
-
Primary chemotherapy in the treatment of inflammatory breast carcinoma: A study of 230 cases from the Institut Gustave-Roussy
-
Rouesse J, Friedman S, Sarrazin D, et al. Primary chemotherapy in the treatment of inflammatory breast carcinoma: a study of 230 cases from the Institut Gustave-Roussy. J Clin Oncol 1986; 4:1765-1771.
-
(1986)
J Clin Oncol
, vol.4
, pp. 1765-1771
-
-
Rouesse, J.1
Friedman, S.2
Sarrazin, D.3
-
7
-
-
0029383127
-
Combined modality treatment of stage III and inflammatory breast cancer. M. D. Anderson Cancer Center experience
-
Buzdar AU, Singletary SE, Booser DJ, et al. Combined modality treatment of stage III and inflammatory breast cancer. M. D. Anderson Cancer Center experience. Surg Oncol Clin N Am 1995; 4:715-734.
-
(1995)
Surg Oncol Clin N Am
, vol.4
, pp. 715-734
-
-
Buzdar, A.U.1
Singletary, S.E.2
Booser, D.J.3
-
8
-
-
0028227197
-
A novel inhibitor of cyclin-CDK activity detected in transforming growth factor beta-arrested epithelial cells
-
Slingerland JM, Hengst L, Pan CH, et al. A novel inhibitor of cyclin-CDK activity detected in transforming growth factor beta-arrested epithelial cells. Mol Cell Biol 1994; 14:3683-3694.
-
(1994)
Mol Cell Biol
, vol.14
, pp. 3683-3694
-
-
Slingerland, J.M.1
Hengst, L.2
Pan, C.H.3
-
9
-
-
0027973043
-
Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27kip1) of cyclin-dependent kinase 4 activation
-
Kato JY, Matsuoka M, Polyak K, et al. Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27kip1) of cyclin-dependent kinase 4 activation. Cell 1994; 79:487-496.
-
(1994)
Cell
, vol.79
, pp. 487-496
-
-
Kato, J.Y.1
Matsuoka, M.2
Polyak, K.3
-
10
-
-
0001208875
-
Cyclin-dependent kinase inbibitor p27 as a mediator of the G1-S phase block induced by 1,25-dihydroxyvitamin D3 in HL60 cells
-
Wang QM, Jones JB, Studzinski GP. Cyclin-dependent kinase inbibitor p27 as a mediator of the G1-S phase block induced by 1,25-dihydroxyvitamin D3 in HL60 cells. Cancer Res 1996; 56:264-267.
-
(1996)
Cancer Res
, vol.56
, pp. 264-267
-
-
Wang, Q.M.1
Jones, J.B.2
Studzinski, G.P.3
-
11
-
-
0032587495
-
P27kip1: A multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers
-
Lloyd RV, Erickson LA, Jin L, et al. P27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am J Pathol 1999; 154:313-323.
-
(1999)
Am J Pathol
, vol.154
, pp. 313-323
-
-
Lloyd, R.V.1
Erickson, L.A.2
Jin, L.3
-
12
-
-
0031439355
-
Promoting apoptosis: A novel activity associated with the cyclin-dependent kinase inhibitor p27
-
Katayose Y, Kim M, Rakkar ANS, et al. Promoting apoptosis: a novel activity associated with the cyclin-dependent kinase inhibitor p27. Cancer Res 1997; 57:5441-5445.
-
(1997)
Cancer Res
, vol.57
, pp. 5441-5445
-
-
Katayose, Y.1
Kim, M.2
Rakkar, A.N.S.3
-
13
-
-
0032012062
-
Cleavage of p21Cip1/Waf1 and p27Kip1 mediates apoptosis in endothelial cells through activation of Cdk2: Role of a caspase cascade
-
Levkau B, Koyama H, Raines EW, et al. Cleavage of p21Cip1/Waf1 and p27Kip1 mediates apoptosis in endothelial cells through activation of Cdk2: role of a caspase cascade. Mol Cell 1998; 1:553-563.
-
(1998)
Mol Cell
, vol.1
, pp. 553-563
-
-
Levkau, B.1
Koyama, H.2
Raines, E.W.3
-
14
-
-
0031689717
-
Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases
-
Thomas GV, Szigeti K, Murphy M, et al. Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases. Am J Pathol 1998; 153:681-687.
-
(1998)
Am J Pathol
, vol.153
, pp. 681-687
-
-
Thomas, G.V.1
Szigeti, K.2
Murphy, M.3
-
15
-
-
0031026190
-
Accumulation of the cyclin-dependent kinase inhibitor p27/kip1 and the timing of oligodendrocyte differentiation
-
Durand B, Gao FB, Raff M. Accumulation of the cyclin-dependent kinase inhibitor p27/kip1 and the timing of oligodendrocyte differentiation. EMBO J 1997; 16:306-317.
-
(1997)
EMBO J
, vol.16
, pp. 306-317
-
-
Durand, B.1
Gao, F.B.2
Raff, M.3
-
16
-
-
0001405430
-
Impact of the cyclin-dependent kinase inhibitor p27kip1 on resistance of tumor cells to anti-cancer agents
-
St Croix B, Florenes VA, Rak JW, et al. Impact of the cyclin-dependent kinase inhibitor p27kip1 on resistance of tumor cells to anti-cancer agents. Nat Med 1996; 2:1204-1210.
-
(1996)
Nat Med
, vol.2
, pp. 1204-1210
-
-
St Croix, B.1
Florenes, V.A.2
Rak, J.W.3
-
17
-
-
16944363001
-
Decreased levels of the cell cycle inhibitor p27Mp1 protein: Prognostic implications in primary breast cancer
-
Catzavelos C, Bhattacharya N, Ung YC, et al. Decreased levels of the cell cycle inhibitor p27Mp1 protein: prognostic implications in primary breast cancer. Nat Med 1997; 3:227-230.
-
(1997)
Nat Med
, vol.3
, pp. 227-230
-
-
Catzavelos, C.1
Bhattacharya, N.2
Ung, Y.C.3
-
18
-
-
0031048716
-
Expression of cell cycle regulators p27kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients
-
Porter PL, Malone KE, Heagerty PJ, et al. Expression of cell cycle regulators p27kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat Med 1997; 3:222-225.
-
(1997)
Nat Med
, vol.3
, pp. 222-225
-
-
Porter, P.L.1
Malone, K.E.2
Heagerty, P.J.3
-
19
-
-
0030894787
-
The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas
-
Tan P, Cady B, Wanner M, et al. The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas. Cancer Res 1997; 57:1259-1263.
-
(1997)
Cancer Res
, vol.57
, pp. 1259-1263
-
-
Tan, P.1
Cady, B.2
Wanner, M.3
-
21
-
-
0032780931
-
Elevated levels of p27, p21 and cyclin D1 correlate with positive oestrogen and progesterone receptor status in node-negative breast carcinoma patients
-
Reed W, Florems VA, Holm R, et al. Elevated levels of p27, p21 and cyclin D1 correlate with positive oestrogen and progesterone receptor status in node-negative breast carcinoma patients. Virchows Arch 1999; 435:116-124.
-
(1999)
Virchows Arch
, vol.4351
, pp. 16-124
-
-
Reed, W.1
Florems, V.A.2
Holm, R.3
-
22
-
-
0242475206
-
Expression of p27kip1 in breast cancer and its prognostic significance
-
Barnes A, Pinder SE, Bell JA, et al. Expression of p27kip1 in breast cancer and its prognostic significance. J Pathol 2003; 201:451-459.
-
(2003)
J Pathol
, vol.201
, pp. 451-459
-
-
Barnes, A.1
Pinder, S.E.2
Bell, J.A.3
-
23
-
-
0034594628
-
New guidelines to evaluate the response to treatment in solid tumors
-
European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada
-
Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000; 92:205-216.
-
(2000)
J Natl Cancer Inst
, vol.92
, pp. 205-216
-
-
Therasse, P.1
Arbuck, S.G.2
Eisenhauer, E.A.3
-
24
-
-
0344629812
-
Jun activation domain binding protein 1 expression is associated with low p27(Kip1) levels in node-negative breast cancer
-
Esteva FJ, Sabin AA, Rassidakis GZ, et al. Jun activation domain binding protein 1 expression is associated with low p27(Kip1) levels in node-negative breast cancer. Clin Cancer Res 2003; 9:5652-5659.
-
(2003)
Clin Cancer Res
, vol.9
, pp. 5652-5659
-
-
Esteva, F.J.1
Sabin, A.A.2
Rassidakis, G.Z.3
-
25
-
-
0033050164
-
Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy
-
Kuerer HM, Newman LA, Smith TL, et al. Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy. J Clin Oncol 1999; 17:460-469.
-
(1999)
J Clin Oncol
, vol.17
, pp. 460-469
-
-
Kuerer, H.M.1
Newman, L.A.2
Smith, T.L.3
-
26
-
-
4644224824
-
Reduced expression of p27 is a novel mechanism of docetaxel resistance in breast cancer cells
-
Brown I, Shalli K, McDonald SL, et al. Reduced expression of p27 is a novel mechanism of docetaxel resistance in breast cancer cells. Breast Cancer Res 2004; 6:601-607.
-
(2004)
Breast Cancer Res
, vol.6
, pp. 601-607
-
-
Brown, I.1
Shalli, K.2
McDonald, S.L.3
|